Biosino Bio-Technology and Science Incorporation Management
Management criteria checks 2/4
We currently do not have sufficient information about the CEO.
Key information
Peng Chen
Chief executive officer
CN¥1.8m
Total compensation
| CEO salary percentage | 100.0% |
| CEO tenure | 2.9yrs |
| CEO ownership | n/a |
| Management average tenure | no data |
| Board average tenure | 1.5yrs |
Recent management updates
Recent updates
Biosino Bio-Technology and Science Incorporation's (HKG:8247) Business And Shares Still Trailing The Industry
Oct 31
Biosino Bio-Technology and Science Incorporation's (HKG:8247) 26% Dip In Price Shows Sentiment Is Matching Revenues
Jun 27Shareholders Will Probably Be Cautious Of Increasing Biosino Bio-Technology and Science Incorporation's (HKG:8247) CEO Compensation At The Moment
Jun 21Biosino Bio-Technology and Science Incorporation (HKG:8247) Held Back By Insufficient Growth Even After Shares Climb 46%
Apr 22Is Biosino Bio-Technology and Science Incorporation (HKG:8247) Using Debt In A Risky Way?
Apr 01Biosino Bio-Technology and Science Incorporation's (HKG:8247) 31% Dip In Price Shows Sentiment Is Matching Revenues
Feb 08Some Confidence Is Lacking In Biosino Bio-Technology and Science Incorporation (HKG:8247) As Shares Slide 38%
Jul 31CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Jun 30 2024 | n/a | n/a | -CN¥19m |
| Mar 31 2024 | n/a | n/a | -CN¥13m |
| Dec 31 2023 | CN¥2m | CN¥2m | -CN¥12m |
| Sep 30 2023 | n/a | n/a | -CN¥9m |
| Jun 30 2023 | n/a | n/a | CN¥2m |
| Mar 31 2023 | n/a | n/a | CN¥4m |
| Dec 31 2022 | CN¥2m | CN¥2m | CN¥8m |
| Sep 30 2022 | n/a | n/a | CN¥2m |
| Jun 30 2022 | n/a | n/a | -CN¥2m |
| Mar 31 2022 | n/a | n/a | -CN¥1m |
| Dec 31 2021 | CN¥95k | CN¥95k | -CN¥1m |
Compensation vs Market: Peng's total compensation ($USD250.30K) is about average for companies of similar size in the Hong Kong market ($USD233.50K).
Compensation vs Earnings: Peng's compensation has been consistent with company performance over the past year.
CEO
Peng Chen (49 yo)
2.9yrs
Tenure
CN¥1,812,000
Compensation
Mr. Chen Peng has been President of Biosino Bio-Technology and Science Incorporation since December 7, 2021 and has been its Executive Director since My 25, 2023 . Mr. Chen has ample experience in corporat...
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & Compliance Officer | 23.6yrs | CN¥1.89m | 2.42% HK$ 2.8m | |
| President & Executive Director | 1.5yrs | CN¥1.81m | no data | |
| Non-Executive Director | 1.5yrs | no data | no data | |
| Supervisor | 5.8yrs | no data | no data | |
| Supervisor | 3.5yrs | no data | no data | |
| Independent Non Executive Director | 3.5yrs | CN¥60.00k | no data | |
| Independent Non-Executive Director | 1.5yrs | CN¥10.00k | no data | |
| Independent Non-Executive Director | 1.8yrs | CN¥50.00k | no data | |
| Non-Executive Vice Chairman | 1.5yrs | no data | no data | |
| Non-Executive Director | 1.5yrs | no data | no data | |
| Non-Executive Vice Chairman of the Board | 1.2yrs | no data | no data | |
| Chairman of the Supervisory Committee | less than a year | no data | no data |
1.5yrs
Average Tenure
55.5yo
Average Age
Experienced Board: 8247's board of directors are not considered experienced ( 1.5 years average tenure), which suggests a new board.